Select Page
Treatment Resistant Depression

Treatment Resistant Depression

Treatment resistant depression (TRD) describes various forms of depression that have undergone treatment and seen minimal, if any, long-term positive results. With depression affecting 6.7% of the United States’ population and over 300 million people worldwide, the...
Brilanta by AstraZeneca Approved to Reduce Risk of Stroke

Brilanta by AstraZeneca Approved to Reduce Risk of Stroke

Brilanta was approved by the U.S. Food and Drug Administration (FDA) for its efficacy in reducing the risk of stroke in patients with acute-ischemic stroke based on the Phase 3 THALES Trial. Compared to aspirin alone, when taken with Brilanta there was a clinically...
FDA Approved Boston Scientific’s Ranger Balloon

FDA Approved Boston Scientific’s Ranger Balloon

The Ranger Drug-Coated Balloon was approved today (10/2) by the U.S. Food and Drug Administration (FDA) for the treatment of patients with peripheral artery disease, a disease that affects 200 million people. The disease is characterized by a plaque build up in the...